InterACT助推干预改善老年临终医院照护的成本-后果分析
该研究基于澳大利亚三家三级医院2020年5月至2021年6月的阶梯楔形整群随机试验,对InterACT助推干预进行成本-后果分析。干预每例高危患者入院平均成本为72澳元,但未降低ICU入住成本、住院时长、医疗急救呼叫或院内死亡,成本差异置信区间宽泛提示不确定性大。结论认为该简单助推干预不足以影响复杂临终场景下的资源使用与成本。
要点
- 干预未降低ICU入住成本、住院时长、医疗急救呼叫或院内死亡。
- 高危入院成本差异95%CI为-2264至3312澳元,不确定性大。
核心结论
- 该成本-后果分析发现干预未能降低无益治疗的成本,与InterACT总体结果一致。
- 简单助推干预单独使用可能不足以影响复杂临终场景下的卫生服务资源使用与成本。
研究设计与样本
- 采用阶梯楔形整群随机试验设计,在澳大利亚三家大型三级医院开展,时间为2020年5月至2021年6月。
- 干预成本通过前瞻性收集的员工时间表、研究文档和现场笔记确定;住院成本与健康服务结局来自医院数据库和病历审查。
主要发现
- 每例被识别的高危患者入院平均干预成本为72澳元。
- 干预未降低ICU入住成本、住院时长、医疗急救呼叫或院内死亡。
- 高危入院成本差异的95%CI为-2264至3312澳元,提示存在很大不确定性。
临床怎么用
- 在老年临终照护场景中,不应仅依赖简单助推干预来降低无益治疗成本。
局限性
- 高危入院成本差异的95%CI宽泛(-2264至3312澳元),提示成本估计存在很大不确定性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The 'Intervention for Appropriate Care and Treatment' (InterACT) was a nudge intervention to identify hospital patients at risk of imminent death or deterioration and communicate this information to treating clinical teams. The aim was to improve the quality of care delivered. This paper reports a cost-consequence analysis of the InterACT intervention. METHODS: A stepped-wedge cluster randomised trial was conducted across three large tertiary hospitals in Australia between May 2020 and June 2021. The cost of implementing the intervention was determined using prospectively collected staff time sheets, study documentation and field notes. Changes to hospital admission costs and health service outcomes between the trial's intervention and control phases are also reported. Hospital admissions costs and other health service outcomes were obtained from hospital databases and patient chart reviews. RESULTS: The mean intervention cost was $A 72 per at-risk patient admission identified. Additional site-level implementation costs ranged between $21 373 to $34 867 per hospital site, translating to $23 per at-risk admission. The intervention did not reduce the cost of intensive care unit admission, length of stay, medical emergency calls or in-hospital deaths. Wide confidence intervals around at-risk admission cost differences (95% CI: -$2264 to $3312) indicated there was large uncertainty. CONCLUSIONS: This cost-consequence analysis found that the intervention was not effective in reducing the cost of non-beneficial treatment, which is consistent with the broader InterACT results. This simple nudge-intervention alone may not be sufficient to impact health service resource use and costs in the complex end-of-life setting.
引用
- Carter HE, Donovan T, White NM, et al. A cost-consequence analysis of a nudge intervention to improve hospital care of older people at the end of life: results from a stepped-wedge cluster randomised trial. Age Ageing. 2025. PMID: 41052263. doi:10.1093/ageing/afaf280
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。